Condition
Depressive Disorder, Major clinical trials and research
As of November 12, 2026, Find a Trial lists 31 Depressive Disorder, Major clinical trials that are recruiting, at sites in 34 countries (most in United States (17), Canada (6), China (5)). By phase: Phase 3 (6), Phase 2 (3), Phase 1 (2), Phase 4 (1). The most active sponsors are Janssen Research & Development, LLC (3), The Royal Ottawa Mental Health Centre (2), Eli Lilly and Company (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 31Clinical trials
- 34Countries
Newest Depressive Disorder, Major clinical trials
All recruiting trials (31)
-
Brenipatide added to standard care for adults with major depressive disorder
This study tests whether brenipatide, given alongside standard care, can help delay the return of depressive symptoms in adults with major depressive disorder.
-
Student Precarity and Psychiatry: How Financial Struggles Relate to Depression and Loneliness
This observational study looks at whether financial hardship and social isolation are linked to depression, suicidal thoughts, and loneliness among French university students.
-
Seltorexant (JNJ-42847922) as monotherapy for adults and older adults with major depressive disorder
This trial will test whether seltorexant works better than a placebo to reduce depressive symptoms in adults and elderly people with major depressive disorder.
-
MOCHA: Inpatient Mental Health Care for High-Risk Pregnancy
This study tests a collaborative mental health program for pregnant or recently postpartum patients hospitalized for medical problems to see if it can be delivered feasibly and acceptably.
-
Brenipatide added to standard antidepressant treatment for adults with major depression
This trial will see if adding brenipatide to your current antidepressant treatment can delay the return of major depressive symptoms in adults with major depressive disorder.
-
Esketamine plus standard care for adolescents with major depressive disorder and acute suicidal thoughts or behavior
This will test whether adding intranasal esketamine to usual care helps hospitalized adolescents with major depressive disorder and acute suicidal thoughts or behavior feel better faster than a psychoactive placebo plus usual care.
-
Everyday movement and subjective energy (MASE Project)
This project tests whether increasing everyday, non-exercise activity can boost feelings of energy and reduce depressive symptoms in people with major depressive disorder or recent remission.
-
Neurofeedback treatment for major depression with anhedonia
This study is testing a new neurofeedback treatment called Prism to see if it can help people with major depression and a lack of pleasure feel better over 24 weeks.
-
Home-based bright light therapy for adolescents with major depressive disorder
This trial will test whether home-based bright light therapy helps adolescents aged 13–17 with major depressive disorder improve mood and emotional and cognitive function.
-
Using Roflumilast with Antidepressants for Major Depression
This study is testing if adding Roflumilast to the antidepressant Fluoxetine can help people with major depression who aren't getting better with their current treatment.
-
Impact of Mediterranean Diet and Mindful Eating on Depression in Obese Individuals
This study is testing if following a Mediterranean Diet and practicing Mindful Eating can help reduce depression in people who are obese and struggling with major depressive disorder.
-
Testing seltorexant for treating major depression with insomnia symptoms
This study is testing if adding a new medication called seltorexant can help adults and older people with major depression and insomnia feel better when their current antidepressants aren't enough.
-
Pilot test of the bWell‑D VR cognitive program for adults with major depression
This pilot will test whether a VR cognitive assessment and an eight‑week VR cognitive training program (bWell‑D) are acceptable and doable for adults with major depressive disorder who report cognitive problems.
-
Comparing two methods of brain stimulation for treating depression in adolescents
This study is testing if a faster way of brain stimulation can help teenagers with hard-to-treat depression feel better compared to the standard method.
-
Testing a new drug for treatment-resistant depression
This study is testing a new drug called HNK to see if it can help people with treatment-resistant depression feel better when other medications haven't worked.
-
Effects of exercise on gut bacteria, mood, and cognition in depression
This study is testing whether a 12-week exercise program can improve mood, thinking, and gut health in people with Major Depressive Disorder.
-
Emotion regulation intervention for depression and healthy individuals
This study is testing a smartphone program that helps people with mild to moderate depression and healthy individuals learn to manage their emotions better and see if it makes a difference in how they feel.
-
Comparing two methods of brain stimulation for treating depression
This study is testing if a personalized brain stimulation method can help people with major depressive disorder feel better compared to the standard treatment.
-
Infliximab treatment for cognitive dysfunction in depressed individuals with inflammation
This study is testing if infliximab can help improve thinking and memory in adults with depression who also have signs of inflammation.
-
Telehealth exercise program to treat depression after brain injury
This study tests whether a telehealth exercise program can help people with depression after a brain injury feel better by encouraging them to be more active.
-
Exploring how ketamine's effects on depression relate to AMPA receptors
This study is testing if blocking certain brain receptors affects how well ketamine helps people with depression who haven't responded to other treatments.
-
Dopamine's effect on motivation and motor function in major depression and inflammation
This study tests if a medication that boosts dopamine can help improve motivation and movement in people with major depression and inflammation.
-
Identifying predictors for treatment response in major depression
This study is trying to find out what factors can help predict how well different treatments will work for people with major depression.
-
Using rTMS to Treat Depression in Veterans with Spinal Cord Injuries
This study is testing a new way to use brain stimulation to help veterans with spinal cord injuries who are struggling with depression.
-
Training veterans with serious mental illness to improve social skills for work
This study is testing a special training program to help veterans with serious mental illnesses improve their social skills for better job interactions.
-
Nociceptin receptor blockade to change approach and avoidance behavior in depression and anxiety.
This trial will test whether a drug that blocks the nociceptin receptor can normalize brain signals and help unmedicated adults with major depression or anxiety make more balanced approach/avoidance decisions.
-
Mitizodone Phosphate tablets for major depressive disorder
This study will try Mitizodone Phosphate tablets in adults with major depressive disorder to see if they improve depressive symptoms compared with placebo.
-
Treatment for depression in borderline personality disorder using brain stimulation
This study is testing if a special type of brain stimulation can help people with borderline personality disorder and depression feel better.
-
Identifying biomarkers for major depression and treatment response
This study is trying to find specific brain markers that can help identify major depression and how well people respond to a new therapy called TMS.
-
Finding the best electrical pulse for electroconvulsive therapy in depression
This study is testing whether a longer electrical pulse during electroconvulsive therapy can help people with depression feel better while causing fewer memory problems.
-
Nitrous oxide targets brain circuits involved in mood
This research will test whether inhaled nitrous oxide changes brain connectivity and improves symptoms in adults with treatment-resistant major depression compared with healthy volunteers.
Related topics
Quick answers
How many Depressive Disorder, Major clinical trials are recruiting right now?
31, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 34 countries. The most sites are in United States (17 trials), Canada (6 trials), China (5 trials), Brazil (5 trials), Germany (5 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 6, Phase 2: 3, Phase 1: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.